| Total | n% | P | |
---|---|---|---|---|
Low expression | High expression | |||
of piRNA-14633 | of piRNA-14633 | |||
Age | Â | Â | Â | Â |
 ≥ 55 (years) | 55 | 25 (45.5%) | 30 (54.5%) | 0.755 |
 < 55 (years) | 39 | 19 (48.7%) | 20 (51.3%) |  |
T stage | Â | Â | Â | Â |
 T1-T2 | 49 | 30 (61.2%) | 19 (38.8%) | 0.003* |
 T3-T4 | 45 | 14 (31.1%) | 31 (68.9%) |  |
N stage | Â | Â | Â | Â |
 N1 | 42 | 27 (64.3%) | 15 (35.7%) | 0.002* |
 N2 | 52 | 17 (32.7%) | 35 (67.3%) |  |
M stage | Â | Â | Â | Â |
 M0 | 34 | 22 (64.7%) | 12 (35.3%) | 0.009* |
 M1 | 60 | 22 (36.7%) | 38 (63.3%) |  |
Tumor size (cm) | Â | Â | Â | Â |
 < 4 | 41 | 25 (61.0%) | 16 (39.0%) | 0.015* |
 ≥ 4 | 53 | 19 (35.8%) | 34 (64.2%) |  |